Adenocarcinoma of Esophagogastric Junction Clinical Trials

16 clinical trials for Adenocarcinoma of Esophagogastric Junction across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique — RECRUITING · NA
• Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma — RECRUITING · PHASE2
• Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) — RECRUITING · PHASE2
• Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma — RECRUITING · PHASE2
• Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction — NOT_YET_RECRUITING · PHASE1
• TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma — OTHER · NA
• Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA — NOT_YET_RECRUITING · PHASE2
• Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• A Modified Esophagogastric Reconstruction Method After Laparoscopic Proximal Gastrectomy — OTHER · NA
• Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric Junction — OTHER · NA
• Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma — OTHER · PHASE2
• Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors — OTHER · NA
• A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors — OTHER · PHASE1
• Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction — OTHER · PHASE3
• Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer — OTHER · PHASE2

Refine this search